Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1Classical hematology 1CNS 1

Conditions

Urinary Tract Infections 1Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Infections 1

Interventions

Docetaxel 409pembrolizumab 331Prednisone 290enzalutamide 285Gemcitabine 274Radiotherapy 270Magnetic Resonance Spectroscopy 269Nivolumab 253Abiraterone Acetate 218Cisplatin 212Leuprolide 195Radiosurgery 192Sunitinib 188Carboplatin 161Androgen Antagonists 156bicalutamide 152Specimen Handling 149Goserelin 149Ipilimumab 131Paclitaxel 126acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 122apalutamide 118Cyclophosphamide 117Bevacizumab 116Sorafenib 114Everolimus 111abiraterone 108cabozantinib 105atezolizumab 105Biopsy 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Fosfomycin × Genitourinary × Clear all
NCT04209192 2023-04-04

Antimicrobial Prophylaxis in Patients Who Underwent a Transurethral Resection of Bladder (TURB)

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Phase 2 Completed
75 enrolled
Genitourinary

Urinary Bladder Neoplasms, Urinary Tract Infections

NCT03228108 2022-05-10

pro-SWAP

Radboud University Medical Center

Phase 4 Completed
1,538 enrolled
Genitourinary

Infections, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡